Summary | The world's 14th-biggest drugmaker already sees signs
its strategy is paying off.Global revenue rose 12 percent, to
nearly $51 billion."The US is the most important country for
Bayer," said global innovation chief Kemal Malik.A key part of
Bayer's US strategy is expanding its consumer health
business.That's been driven by its 2014 purchase of Merck & ...
its strategy is paying off.Global revenue rose 12 percent, to
nearly $51 billion."The US is the most important country for
Bayer," said global innovation chief Kemal Malik.A key part of
Bayer's US strategy is expanding its consumer health
business.That's been driven by its 2014 purchase of Merck & ...
en.ce.cn | 30 April 2016